Display options
Cite
Venter F, Majam M, Jankelowitz L, et al. South African HIV self-testing policy and guidance considerations. South Afr J HIV Med. 2017;18(1):775doi: 10.4102/sajhivmed.v18i1.775.
Venter, F., Majam, M., Jankelowitz, L., Adams, S., Moorhouse, M., Carmona, S., Stevens, W., Msimanga, B. R., Allen, D., Balani, P., Nevhutalu, Z., Rhagnath, N., Shroufi, A., Devillé, W., Kazangarare, V., van der Wiel, R., Templeman, H., Puren, A., Tucker, T., van Cutsem, G., Conradie, F., Dong, K., Chidarikire, T., & Gray, A. (2017). South African HIV self-testing policy and guidance considerations. Southern African journal of HIV medicine, 18(1), 775. https://doi.org/10.4102/sajhivmed.v18i1.775
Venter, Francois, et al. "South African HIV self-testing policy and guidance considerations." Southern African journal of HIV medicine vol. 18,1 (2017): 775. doi: https://doi.org/10.4102/sajhivmed.v18i1.775
Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A. South African HIV self-testing policy and guidance considerations. South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017. PMID: 29568643; PMCID: PMC5842980.
Copy Download .nbib Format: NLM
Share it on

South Afr J HIV Med. 2017 Sep 22;18(1):775. doi: 10.4102/sajhivmed.v18i1.775. eCollection 2017.

South African HIV self-testing policy and guidance considerations.

Southern African journal of HIV medicine

Francois Venter, Mohammed Majam, Lauren Jankelowitz, Siraaj Adams, Michelle Moorhouse, Sergio Carmona, Wendy Stevens, Busisiwe R Msimanga, David Allen, Pooja Balani, Zwoitwaho Nevhutalu, Naleni Rhagnath, Amir Shroufi, Walter Devillé, Victoria Kazangarare, Renee van der Wiel, Hugo Templeman, Adrian Puren, Tim Tucker, Gilles van Cutsem, Francesca Conradie, Krista Dong, Thato Chidarikire, Andy Gray

Affiliations

  1. HIV Management Cluster, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
  2. Southern African HIV Clinicians Society, Johannesburg, South Africa.
  3. Wits Reproductive Health and HIV Institute, University of the Witwatersrand, South Africa.
  4. National Health Laboratory Service, Johannesburg, South Africa.
  5. Department of Haematology, University of the Witwatersrand, South Africa.
  6. World Health Organization, South Africa.
  7. Bill and Melinda Gates Foundation, Johannesburg, South Africa.
  8. South African National AIDS Council, Pretoria, South Africa.
  9. Médecins Sans Frontières, Southern Africa.
  10. Ndlovu Care Group, Groblersdal, South Africa.
  11. Utrecht University Medical Center, Utrecht University, the Netherlands.
  12. PSI, Johannesburg, South Africa.
  13. Society for Family Health, Johannesburg, South Africa.
  14. Wits Institute For Social & Economic Research, University of the Witwatersrand, South Africa.
  15. National Institute for Communicable Diseases, Johannesburg, South Africa.
  16. Strategic Evaluation, Advisory and Development Consulting (SEAD), Johannesburg, South Africa.
  17. Department of Medicine, University of Cape Town, South Africa.
  18. iTEACH, Denton, United States.
  19. Massachusetts General Hospital, Boston, United States.
  20. National Department of Health, Pretoria, South Africa.
  21. Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, South Africa.

PMID: 29568643 PMCID: PMC5842980 DOI: 10.4102/sajhivmed.v18i1.775

Abstract

The gap in HIV testing remains significant and new modalities such as HIV self-testing (HIVST) have been recommended to reach key and under-tested populations. In December 2016, the World Health Organization (WHO) released the Guidelines on HIV Self-Testing and Partner Notification: A Supplement to the Consolidated Guidelines on HIV Testing Services (HTS) and urged member countries to develop HIVST policy and regulatory frameworks. In South Africa, HIVST was included as a supplementary strategy in the National HIV Testing Services Policy in 2016, and recently, guidelines for HIVST were included in the South African National Strategic Plan for HIV, sexually transmitted infections and tuberculosis 2017-2022. This document serves as an additional guidance for the National HIV Testing Services Policy 2016, with specific focus on HIVST. It is intended for policy advocates, clinical and non-clinical HTS providers, health facility managers and healthcare providers in private and public health facilities, non-governmental, community-based and faith-based organisations involved in HTS and outreach, device manufacturers, workplace programmes and institutes of higher education.

Conflict of interest statement

The donor did not participate in or influence the process of guideline development. A.G. is a member of the Medicines Control Council (which will regulate in vitro diagnostics, including HIVST), and t

Publication Types

Grant support